Skip to content

A comparative study on the curative effect of acupoint application on patients in remission of allergic asthma which based on the lung-gut axis theory

A comparative study on the curative effect of acupoint application on patients in remission of allergic asthma which based on the lung-gut axis theory

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004320
Enrollment
Unknown
Registered
2020-10-24
Start date
2021-07-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Cases that are clearly diagnosed according to the diagnostic criteria of western medicine for asthma and are in the acute stage of non-asthma; (2) Remission period of asthma in accordance with TCM syndrome differentiation standards; (3) Do not use other immune enhancers, do not inhale glucocorticoids or other drugs or short-term inhalation of glucocorticoids (less than 1 month per year) during the treatment; (4) Aged from 18 to 65 years; (5) Those who sign an informed consent and are willing to follow the research plan.

Exclusion criteria

Exclusion criteria: (1) Patients with other diseases that can cause asthma or breathing difficulties; (2) Pregnant and lactating women who are allergic to the prescription drugs in this trial; (3) Those who suffer from heart failure, moderate to severe hypertension, diabetes, and other blood system diseases or mental illnesses who cannot cooperate; (4) People with scar constitution or history of tape allergy, or unhealed wounds exposed in acupoint application; (5) Other diseases that are not suitable for acupoint application.

Design outcomes

Primary

MeasureTime frame
Clinical efficacy score;Self-rating anxiety scale;Depression self-rating scale score;Adult asthma quality of life score;

Secondary

MeasureTime frame
Serum related immune index;

Countries

China

Contacts

Public ContactYutong Jin
379757201@qq.com+86 15168335422

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026